Erasca appoints Charles Fuchs, former Tubulis CMO, as president of research and development

STAT+ columnist Ed Silverman highlighted a recent personnel change in the pharmaceutical sector. The regular "comings and goings" feature tracks hires, promotions, and departures across the industry.

Erasca announced the hiring of Charles Fuchs to lead its research and development division as president. The move is part of the company's effort to strengthen its pipeline and scientific leadership.

Fuchs joins Erasca after serving as chief medical officer at Tubulis, bringing experience in drug development and clinical strategy to his new role.